Page last updated: 2024-08-21

vancomycin and Chronic Bullous Disease of Childhood

vancomycin has been researched along with Chronic Bullous Disease of Childhood in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's16 (76.19)24.3611
2020's5 (23.81)2.80

Authors

AuthorsStudies
Adachi, M; Adachi, T; Ichimura, C; Ishii, K; Ishiko, A; Yokota, M; Yoshida, K1
Abadías-Granado, I; Gilaberte, Y; Gomez-Mateo, MC; Navarro-Bielsa, A1
Gallitano, SM; Husain, S; Kwinta, BD; Queen, D1
Blanc, J; Clerté, M; Morel, P; Ridel, C; Schurder, J; Touzot, M1
Cho, C; Kobayashi, T; Phyu, H; Rastogi, P1
Abu Saleh, OM; Go, JR1
Ishiko, A; Morii, K; Yoshida, K; Yoshihama, E1
Salonen, BR; Vinnakota, S1
Amagai, M; Fujimoto, N; Funakoshi, T; Hachiya, T; Hashimoto, T; Ishida-Yamamoto, A; Ishii, N; Nagao, K; Nakamura, Y; Nishigori, C; Takahashi, H; Tanaka, T; Tanikawa, A; Yamagami, J; Yamamoto, T; Yoshida, T1
Boulavsky, J; Dao, H; Diwan, AH; Gill, BJ; Koshelev, MV; Nguyen, JK1
K Heng, Y; Kuan, LY; Lim, YL; Pan, JY; Tan, CH; Tan, LS; Tee, SI1
Diiorio, DA; Fine, JD; Livingood, MR; Powers, JG; Riemenschneider, K; Tkaczyk, E; Zic, JA; Zwerner, JP1
Berg, SA; Chu, EY1
Afriat, D; Bara Passot, C; Barbaud, A; Bensaid, B; Beylot-Barry, M; Caux, F; Descamps, V; Duvert-Lehembre, S; Garel, B; Grootenboer-Mignot, S; Ingen-Housz-Oro, S; Jeudy, G; Lebrun-Vignes, B; Prost-Squarcioni, C; Soria, A; Tétart, F; Valnet-Rabier, MB1
Biedermann, T; Hein, R; Lammer, J; Roenneberg, S; Volz, T1
Hashimoto, T; Koga, H; Konishi, K; Tashima, S1
Eto, H; Hashimoto, T; Koga, H; Nakano, T; Zenke, Y1
Choudhry, SZ; Kashat, M; Lim, HW1
Meyerle, JH; Peterson, DJ; Sperling, LC; Spillane, EL; Winn, AE1
Gameiro, A; Goncalo, M; Gouveia, M; Tellechea, O1
Burillo-Martinez, S; Ortiz-Romero, PL; Prieto-Barrios, M; Rodriguez-Peralto, JL; Tous-Romero, F; Velasco-Tamariz, V; Zarco-Olivo, C1

Reviews

2 review(s) available for vancomycin and Chronic Bullous Disease of Childhood

ArticleYear
Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
    Acta dermato-venereologica, 2019, May-01, Volume: 99, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Humans; Linear IgA Bullous Dermatosis; Male; Vancomycin

2019
Vancomycin-induced linear IgA bullous dermatosis: associations.
    Dermatology online journal, 2016, Apr-18, Volume: 22, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Facial Dermatoses; Humans; Leg Dermatoses; Linear IgA Bullous Dermatosis; Male; Middle Aged; Vancomycin

2016

Other Studies

19 other study(ies) available for vancomycin and Chronic Bullous Disease of Childhood

ArticleYear
A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    The Journal of dermatology, 2021, Volume: 48, Issue:12

    Topics: Anti-Bacterial Agents; Exanthema; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Stevens-Johnson Syndrome; Vancomycin

2021
Vancomycin-induced linear IgA bullous dermatosis.
    Medicina clinica, 2022, 07-22, Volume: 159, Issue:2

    Topics: Anti-Bacterial Agents; Drug Eruptions; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Vancomycin

2022
Drug-Induced Linear IgA Bullous Dermatosis Mimicking Stevens-Johnson Syndrome Treated With Etanercept: A Case Report.
    The American Journal of dermatopathology, 2023, 03-01, Volume: 45, Issue:3

    Topics: Anti-Bacterial Agents; Etanercept; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Stevens-Johnson Syndrome; Vancomycin

2023
Skin lesions and vancomycin use in a hemodialysis patient.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2019, Volume: 23, Issue:4

    Topics: Adult; Humans; Linear IgA Bullous Dermatosis; Male; Prognosis; Renal Dialysis; Vancomycin

2019
Vancomycin-induced linear Immunoglobulin A bullous dermatosis.
    BMJ case reports, 2019, Dec-09, Volume: 12, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Female; Humans; Linear IgA Bullous Dermatosis; Prosthesis-Related Infections; Skin Diseases, Vesiculobullous; Treatment Outcome; Vancomycin

2019
Vancomycin-Induced Linear IgA Bullous Dermatosis.
    The New England journal of medicine, 2020, Oct-15, Volume: 383, Issue:16

    Topics: Aged; Anti-Bacterial Agents; Basement Membrane; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Myositis; Osteomyelitis; Skin; Vancomycin

2020
Blister fluid is a useful diagnostic tool for diagnosis of vancomycin-induced linear IgA bullous dermatosis.
    The Journal of dermatology, 2021, Volume: 48, Issue:11

    Topics: Anti-Bacterial Agents; Blister; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Vancomycin

2021
Linear IgA bullous dermatosis: A rare manifestation of vancomycin hypersensitivity.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:1

    Topics: Aged, 80 and over; Allergens; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Drug Hypersensitivity; Exanthema; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Prednisone; Skin; Vancomycin

2018
Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Autoantibodies; Autoantigens; Autoimmunity; Basement Membrane; Biopsy; Calcinosis; Collagen Type VII; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Mixed Connective Tissue Disease; Prednisolone; Serologic Tests; Skin; Skin Ulcer; Vancomycin

2018
A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
    Dermatology online journal, 2017, Aug-15, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Diagnosis, Differential; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Stevens-Johnson Syndrome; Vancomycin

2017
A polymorphous rash of an uncommon blistering disease.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:7

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Betamethasone; Blister; Diagnosis, Differential; Exanthema; Glucocorticoids; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Piperacillin, Tazobactam Drug Combination; Prednisolone; Treatment Outcome; Vancomycin

2018
Drug-induced linear IgA bullous dermatosis in a patient with a vancomycin-impregnated cement spacer.
    Cutis, 2018, Volume: 101, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Bone Cements; Humans; Knee Prosthesis; Linear IgA Bullous Dermatosis; Male; Vancomycin

2018
SnapshotDx Quiz: July 2018.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:7

    Topics: Anti-Bacterial Agents; Cellulitis; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Vancomycin

2018
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Databases, Factual; Diagnosis, Differential; Doxycycline; Drug Monitoring; Enoxaparin; Female; France; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Minocycline; Pharmacovigilance; Prevalence; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Vancomycin; Young Adult

2019
A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    International journal of dermatology, 2014, Volume: 53, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Autoantibodies; Autoantigens; Collagen Type XVII; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Non-Fibrillar Collagens; Pemphigoid, Bullous; Protein Structure, Tertiary; Vancomycin

2014
A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    The British journal of dermatology, 2014, Volume: 170, Issue:4

    Topics: Anti-Bacterial Agents; Antibodies; Drug Eruptions; Endocarditis, Bacterial; Humans; Immunoglobulin A; Laminin; Linear IgA Bullous Dermatosis; Male; Middle Aged; Vancomycin

2014
Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
    International journal of dermatology, 2015, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; Brain Diseases; Clostridioides difficile; Drug Eruptions; Enterocolitis, Pseudomembranous; Fatal Outcome; Female; Humans; Linear IgA Bullous Dermatosis; Middle Aged; Mouth Diseases; Vancomycin

2015
False-negative direct immunofluorescence testing in vancomycin-induced linear IgA bullous dermatosis: a diagnostic pitfall.
    Journal of cutaneous pathology, 2016, Volume: 43, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Drug Eruptions; False Negative Reactions; Female; Fluorescent Antibody Technique, Direct; Humans; Linear IgA Bullous Dermatosis; Vancomycin

2016
Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.
    The British journal of dermatology, 2018, Volume: 178, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Dermatologic Agents; Diagnosis, Differential; Etanercept; Female; Humans; Linear IgA Bullous Dermatosis; Stevens-Johnson Syndrome; Treatment Outcome; Vancomycin

2018